Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 237

1.

[Role of transforming growth factor beta1 (TGF-beta1) in the pathogenesis and clinical course of chronic hepatitis in children].

Liberek A, Marek A, Kmieć Z, Kartanowicz D, Szlagatys-Sidorkiewicz A, Łuczak G, Wierzbicki PM, Stanisławowski M, Wierzbicki M, Marek K, Liberek T, Sikorska-Wiśniewska G, Góra-Gebka M, Wegrzyn G, Kamińska B.

Med Wieku Rozwoj. 2009 Jul-Sep;13(3):163-70. Polish.

PMID:
20081261
[PubMed - indexed for MEDLINE]
2.

[Gene polymorphism of transforming growth factor beta1 (TGF-beta1) in the pathogenesis and clinical course of chronic hepatitis in children].

Liberek A, Jakóbkiewicz-Banecka J, Kloska A, Swiderska J, Marek A, Łuczak G, Wierzbicki PM, Kmieć Z, Szlagatys-Sidorkiewicz A, Marek K, Sznurkowska K, Góra-Gebka M, Liberek T, Zagierski M, Kamińska B, Wegrzyn G.

Med Wieku Rozwoj. 2009 Jul-Sep;13(3):171-9. Polish.

PMID:
20081262
[PubMed - indexed for MEDLINE]
3.

[Serum aminoterminal peptide of type III procollagen (PIIINP) and transforming growth factor-beta1 (TGF-beta1) levels in patients with chronic hepatitis B and C].

Marek B, Kajdaniuk D, Janczewska-Kazek E, Beniowski M, Swietochowska E, Kos-Kudła B, Ostrowska Z, Mazurek U, Wilczok T, Nowak M, Siemińska L, Borgiel-Marek H, Strzyzewski A, Januła A, Sierek K, Niedzielski Z.

Pol Arch Med Wewn. 2003 Jun;109(6):603-8. Polish.

PMID:
14567092
[PubMed - indexed for MEDLINE]
4.

Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.

Flisiak R, Maxwell P, Prokopowicz D, Timms PM, Panasiuk A.

Hepatogastroenterology. 2002 Sep-Oct;49(47):1369-72.

PMID:
12239944
[PubMed - indexed for MEDLINE]
5.

Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.

Ben-Ari Z, Pappo O, Druzd T, Sulkes J, Klein T, Samra Z, Gadba R, Tambur AR, Tur-Kaspa R, Mor E.

Cytokine. 2004 Jul 7;27(1):7-14.

PMID:
15207246
[PubMed - indexed for MEDLINE]
6.
7.

Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.

Sakaguchi K, Kitano M, Nishimura M, Senoh T, Ohta T, Terao M, Shinji N, Koide N, Tsuji T.

Hepatogastroenterology. 2004 Nov-Dec;51(60):1780-3.

PMID:
15532825
[PubMed - indexed for MEDLINE]
8.

TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients.

El Bassuoni MA, Talaat RM, Ibrahim AA, Shaker OT.

Egypt J Immunol. 2008;15(1):39-50.

PMID:
20306668
[PubMed - indexed for MEDLINE]
9.

Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B.

Flisiak R, Al-Kadasi H, Jaroszewicz J, Prokopowicz D, Flisiak I.

World J Gastroenterol. 2004 Sep 15;10(18):2661-5.

PMID:
15309715
[PubMed - indexed for MEDLINE]
Free Article
10.

-509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.

Qi P, Chen YM, Wang H, Fang M, Ji Q, Zhao YP, Sun XJ, Liu Y, Gao CF.

Cancer Immunol Immunother. 2009 Sep;58(9):1433-40. doi: 10.1007/s00262-009-0660-4. Epub 2009 Jan 25.

PMID:
19169878
[PubMed - indexed for MEDLINE]
11.

Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.

Dong ZZ, Yao DF, Yao M, Qiu LW, Zong L, Wu W, Wu XH, Yao DB, Meng XY.

Hepatobiliary Pancreat Dis Int. 2008 Jun;7(3):288-95.

PMID:
18522884
[PubMed - indexed for MEDLINE]
Free Article
12.

Effects of interferon plus ribavirin treatment on NF-kappaB, TGF-beta1, and metalloproteinase activity in chronic hepatitis C.

Guido M, De Franceschi L, Olivari N, Leandro G, Felder M, Corrocher R, Rugge M, Pasino M, Lanza C, Capelli P, Fattovich G.

Mod Pathol. 2006 Aug;19(8):1047-54. Epub 2006 May 12.

PMID:
16699498
[PubMed - indexed for MEDLINE]
Free Article
13.

Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B.

Akpolat N, Yahsi S, Godekmerdan A, Demirbag K, Yalniz M.

World J Gastroenterol. 2005 Jun 7;11(21):3260-3.

PMID:
15929178
[PubMed - indexed for MEDLINE]
Free Article
14.

Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B.

Lebensztejn DM, Sobaniec-Lotowska M, Kaczmarski M, Werpachowska I, Sienkiewicz J.

Hepatogastroenterology. 2004 Jan-Feb;51(55):229-33.

PMID:
15011870
[PubMed - indexed for MEDLINE]
15.

Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity.

Bayer EM, Herr W, Kanzler S, Waldmann C, Meyer Zum Büschenfelde KH, Dienes HP, Lohse AW.

J Hepatol. 1998 May;28(5):803-11.

PMID:
9625315
[PubMed - indexed for MEDLINE]
16.

Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.

Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R.

J Viral Hepat. 2009 Jul;16(7):513-8. doi: 10.1111/j.1365-2893.2009.01103.x. Epub 2009 Feb 5.

PMID:
19200132
[PubMed - indexed for MEDLINE]
17.

[Level of serum and liver tissue TGF-beta1 in patients with liver fibrosis due to chronic hepatitis B].

Guo JC, Bao JF, Chen QW, Li XO, Shi JP, Lou GQ, Shi WZ, Xun YH.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Oct;22(5):354-7. Chinese.

PMID:
19469173
[PubMed - indexed for MEDLINE]
18.

TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy.

Marek B, Kajdaniuk D, Mazurek U, Janczewska-Kazek E, Kos-Kudla B, Strzalka B, Fila A, Niedziolka D, Beniowski M, Ostrowska Z, Borgiel-Marek H, Kajdaniuk J, Sieminska L, Nowak M, Wilczok T, Pakula D, Filipczyk P.

J Clin Pharm Ther. 2005 Jun;30(3):271-7.

PMID:
15896245
[PubMed - indexed for MEDLINE]
19.

[Quantitative assessment of mRNA TGF-beta1 in liver tissue in connection with serum mean daily level of TGF-1 in chronic hepatitis B patient].

Marek B, Kajdaniuk D, Mazurek U, Janczewska-Kazek E, Strzałka B, Beniowski M, Kos-Kudła B, Kajdaniuk J, Niedziołka D, Ostrowska Z, Borgiel-Marek H, Siemińiska L, Nowak M, Pakuła D, Gatnar A, Gnot R, Filipczyk P.

Pol Arch Med Wewn. 2005 Aug;114(2):738-45. Polish.

PMID:
16808311
[PubMed - indexed for MEDLINE]
20.

Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats.

Roulot D, Sevcsik AM, Coste T, Strosberg AD, Marullo S.

Hepatology. 1999 Jun;29(6):1730-8.

PMID:
10347115
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk